Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen. With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other News
- pharma& Secures MHRA Approval for Pegasys API Production at Loba Biotech May 28, 2025 9:55 pm pharmaand GmbH (pharma&) has received a regulatory variation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), authorizing its wholly owned subsidiary, Loba biotech GmbH, as an approved manufacturing site for the API in Pegasys …
- Business News | Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3% May 27, 2025 10:43 am NewsVoir New Delhi [India], May 27: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter and fiscal year ending March 31, 2025 …
- Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025 May 20, 2025 2:22 pm Big data, Artificial Intelligence (AI), Machine Learning (ML) and other emerging technologies are transforming the pharmaceutical industry right before our eyes – and the clock is ticking for companies that haven’t yet adapted. Integrating these tools into …
- Small Molecule Pharma Companies Are Employing These Advanced Technologies To Get Ahead May 19, 2025 5:35 pm By Joseph Pategou Small molecule therapeutics account for over 50 percent of global pharmaceutical sales and nearly 70 percent of new FDA approvals in recent years, underscoring their continued dominance in medicine delivery.1 Every day, millions rely on …
- Top stocks to watch: Dr Reddy's, BEL, Divis Labs, Bajaj Auto, Sun Pharma, JSW Steel & Premier Energies May 19, 2025 3:16 am Indian benchmark indices settled lower on Friday amid profit booking despite positive economic data, rate cut hopes and trade deal expectations with the US. BSE Sensex shed 200.15 points, or 0.24 per cent to settle at 82,330.59, while NSE's Nifty50 …
- Stocks to watch on news today: Dr Reddy’s, Sun Pharma, BEL, JSW Steel, NBCC, Max Healthcare, PNC Infra in focus May 19, 2025 2:21 am Several companies are likely to remain in focus today owing to key regulatory updates, project wins, acquisitions, and strategic corporate announcements. Dr Reddy’s Laboratories received two observations in Form 483 from the USFDA following a GMP …
- Niner Pharma Announces Entry into US Market with 99% Purity Peptides May 13, 2025 1:53 pm Breadcrumb Trail Links Newsfile Article content Dubai, United Arab Emirates–(Newsfile Corp. – May 13, 2025) – Niner Pharma, a leading global API and pharmaceutical manufacturer, today announced plans to enter the US market with its 99% purity peptides. The …
- ETMarkets Smart Talk: From comfort zone to opportunity zone - why large caps may lag behind, says Madanagopal Ramu May 13, 2025 6:09 am As global trade dynamics shift and India emerges stronger with policy tailwinds and capital readiness, investors must rethink their equity strategy. In this edition of ETMarkets Smart Talk, Madanagopal Ramu, CIO and Head – Equity at Sundaram Alternate …
- Onshoring Pharma Ops: Reading Recent EO and Policy Tea Leaves May 10, 2025 12:43 am This week, underscoring a commitment to national security, the White House and the Food and Drug Administration (FDA) issued separate communications that aim to bolster domestic drug manufacturing while tightening oversight of foreign facilities. But they …
- Business News | Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs In APIs Via Green Chemistry May 9, 2025 7:26 am PNN New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform …
- Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) To Present At D. Boral Capital Inaugural Global Conference May 5, 2025 7:00 pm (MENAFN- Investor Brand Network) NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage company developing broad-spectrum antivirals using host-mimetic nanomedicine technology, will participate in the D. Boral Capital Inaugural Global Conference on …
- 'We should not have tariffs' on pharma: Pfizer CEO April 29, 2025 5:35 pm Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure, he said Tuesday, the government's national security concerns are …
- Tritica Biosciences Develops Wheat-Based Protein Synthesis Platform April 28, 2025 3:00 pm From fields to pharma: Tritica Biosciences and partners launch WHEAT project to transform drug manufacturing. WAMEGO, KS, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- From fields to pharmaceuticals: a Kansas company is redefining what …
- Stocks in news: HDFC Bank, ICICI Bank, Emcure Pharma, TCS, NIIT, Adani Ports, Zydus, Adani Green among top stocks to watch on April 21 April 21, 2025 2:10 am A packed day for equity markets awaits investors with multiple stocks poised to remain in focus today, driven by corporate developments, quarterly earnings announcements, and rating upgrades. In the pharmaceutical sector, Emcure Pharma received an …
- Growth at reasonable price our core focus; underweight banks and IT: Sumit Jain, ASK Investment Managers April 19, 2025 7:21 am As markets grapple with heightened volatility driven by geopolitical uncertainty and global macro headwinds, Sumit Jain, Deputy CIO at ASK Investment Managers, says the firm is staying the course with a disciplined focus on quality and growth. In an …
- Dr Reddy’s layoffs: Pharma major to cut workforce cost by 25%? Here's what the drugmaker says April 14, 2025 1:31 pm Dr Reddy's layoffs: Dr Reddy's Laboratories has categorically denied media reports claiming that the leading pharmaceutical major will likely cut its workforce costs by nearly 25 per cent as it begins a significant downsizing initiative. In a …
- US-China trade war: How India can turn crisis into opportunity April 13, 2025 8:08 am The White House clarified that the levies on Chinese imports stand at 145 per cent—the 125 per cent tariff announced by President Donald Trump is in addition to the two hikes of 10 per cent post-Trump taking office. China’s unflinching approach has made …
- India's Pharma Industry Is Not Immune To The Spread Of AI March 25, 2025 11:18 pm -Analysis- NEW DELHI — With nearly one-fifth of the global supply chain and 60% of the worldwide vaccine supply, the Indian pharmaceutical industry is a dominant global player. India has the highest number of U.S. Food and Drug Administration-approved …
- Trump tariffs drive pharma manufacturing to US but risk inflation and disruption March 25, 2025 11:59 am The pharma industry has been left reeling by the recent news of US government trade tariffs, with companies Eli Lilly (Indianapolis, IN, US), Pfizer (New York, NY, US) and Merck & Co (Kenilworth, NJ, US) boosting their US manufacturing presence to …
- Alembic Pharmaceuticals completes USFDA inspection at Karakhadi API-III facility with zero observations March 22, 2025 4:55 am Alembic Pharmaceuticals Limited has successfully concluded a scheduled inspection by the United States Food and Drug Administration (USFDA) at its API-III manufacturing facility located in Karakhadi, Gujarat. The Good Manufacturing Practices (GMP) …
- The Future of Pharmaceutical Excipients: A $14 Billion Market Driven by Global Demand March 20, 2025 4:12 pm The pharmaceutical industry is undergoing a significant transformation, with excipients, active pharmaceutical ingredients (APIs), and functional excipients playing increasingly crucial roles in drug development and delivery. As we look towards the future, …
- DCAT Member Companies Present Latest News to Start DCAT Week 2025 March 17, 2025 8:17 pm Twenty companies from all corners of the bio/pharmaceutical industry provided updates on their latest developments at the inaugural event of the Drug, Chemical & Associated Technologies Association (DCAT)’s annual gathering, DCAT Week, at the …
- The NIFTY and the Sensex Trying To Rally amid Highly Volatile Global Trends: Market This week March 7, 2025 3:14 pm Indian benchmark indices closed relatively flat on Friday, ending their two-day winning streak. The BSE Sensex edged down 7.51 points (0.01%) to 74,332.58, while the Nifty 50 inched up 7.80 points (0.03%) to 22,552.50. Market sentiment remains cautious, …
- Stocks in news: TCS, Wipro, Dalmia Bharat, Zydus Life, LIC Housing, Hindustan Zinc & IRFC March 6, 2025 2:53 am Indian benchmark indices snapped the 10-day losing streak to settle with decent gains on Wednesday on the back of weakness in the US Dollar leading to a relief rally. BSE Sensex jumped 740.30 points, or 1.01 per cent, to end at 73,730.23. NSE's Nifty50 …
- Stocks To Watch: From TCS to Wipro- Here’s a list of 10 stocks in news today March 6, 2025 2:26 am Markets are always buzzing with action. Some of the biggest names in IT, finance, pharma, and infrastructure have announced key developments that could influence their stock performance. Whether it’s a new partnership, a major fundraising plan, or a …
- Fierce Pharma Asia—Eisai's US restructuring; China investigates former NMPA official; Pfizer-Summit collab February 28, 2025 4:19 pm Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. Pfizer has formed a clinical trial collaboration with Akeso's partner Summit Therapeutics. And …
- Global High Potency Active Pharmaceutical Ingredients Market to Surpass USD 45 Billion Mark by 2032 | DelveInsight February 27, 2025 11:38 pm The high-potency active pharmaceutical ingredients market is growing rapidly, driven mainly by the increasing global burden of chronic diseases. Key factors contributing to this expansion include the rising prevalence of cancer and diabetes, greater …
- Stocks in news: Bharti Airtel, Dr Reddy’s, BEL, UltraTech, Adani Green, Tata Power & SpiceJet February 27, 2025 2:48 am Ahead of Wednesday's holiday, Indian benchmark indices settled on a mixed note on Tuesday due to muted global cues and key economic data later this week amid the dull sentiments over valuations and tariff concerns. BSE Sensex gained 147.71 points, or 0 …
- Zealand Pharma Announces Financial Results for the Full Year 2024 February 20, 2025 6:00 am Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity pipeline, while building the foundation for accelerated …
- Stocks in news: Waaree Energies, Cyient, Bharat Forge, IREDA, Tata Tech, Patanjali & RITES February 20, 2025 2:51 am Indian benchmark indices settled slightly lower on Wednesday amid mixed global and domestic cues. BSE Sensex shed 28.21 points, or 0.04 per cent, to end at 75,939.18. NSE's Nifty50 declined 12.40 points, or 0.05 per cent, to settle at 22,932.90. Here …
- Stocks To Watch: From Bharat Forge to Waaree Energies- Here’s a list of 10 stocks in news today February 20, 2025 1:41 am Every trading day has its stars and strugglers. As the markets gear up for another trading session today, February 20, certain stocks are catching the spotlight. From major deals to policy shifts, here is a look at the stocks that are in focus. Market …
- Stocks in news: Wipro, BHEL, Shriram Finance, ABB India, RVNL Glenmark Pharma & ABFRL February 17, 2025 2:19 am Indian benchmark indices continued to tumble for the eight straight session and ended in red on Friday on the back of weak Q3 earnings, consistent FII selling, trade tariffs tantrums in the US. BSE Sensex shed 199.76 points, or 0.26 per cent, to end at 75, …
- Stocks in news: HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro February 17, 2025 1:10 am Equity markets remained volatile on Friday, shedding nearly half a percent amid mixed cues. In today's trade, shares of HFCL, BHEL, Glenmark Pharma, ABFRL, Wipro among others will be in focus due to various news developments. HFCL Domestic telecom gear …
- Business News | India's CDMO Market Set to Double by 2028 Amid Asia's Healthcare Boom February 9, 2025 9:23 am New Delhi [India], February 9 (ANI): India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to expand from USD 7 billion to USD 14 billion by 2028, capturing 4-5 per cent of the global …
- Pharmaceutical Intermediates Global Market 2024 Report Highlights Strong Growth Potential February 6, 2025 11:05 pm Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! The Business Research Company presents the Pharmaceutical Intermediates Global Market Report 2024, which outlines the substantial growth potential …
- Sun Pharma shares in focus after Q3 profit beats estimates; Nuvama raises target price February 1, 2025 3:20 am Sun Pharma shares will be in focus on Saturday after the company reported a 15% year-on-year (YoY) increase in consolidated net profit to Rs 2,903 crore for the quarter ended December 2024. This includes an exceptional item of Rs 316 crore. The profit …
- Global Virology Market is Expected to Reach USD 3,808.9 Million by 2035, Driven by Developments in Antiviral Drugs, Diagnostics, and Vaccines | Future Market Insights, Inc. January 22, 2025 1:30 pm NEWARK, Del, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The virology market is projected to grow from USD 2,333.2 million in 2025 to USD 3,808.9 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.0%. This growth is primarily attributed to the …
- INDIA API Market Gaining Ground at 8.50% CAGR to Reach 38.13 Billion USD by 2032 January 20, 2025 2:45 pm INDIA API Market Insights: India remains a leading producer of APIs, with robust growth in domestic and export demand. US, NY, UNITED STATES, January 20, 2025 /EINPresswire.com/ -- Market Research Future Latest Industry Insights on “India API …
- Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma January 16, 2025 12:30 pm TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based …
- Optimizing Outsourcing: A Case Study On Evaluating CDMO Capabilities For API And FD Development January 3, 2025 12:14 am (MENAFN- PR Newswire) A large Pharmaceutical company collaborated with DelveInsight to evaluate CDMO companies for API and FD development. DelveInsight provided a comprehensive one-time report benchmarking top contract development and manufacturing …
- Manappuram Finance, IPCA Labs, Torrent Pharma, V-Guard: SMC picks 4 stocks, says this December 23, 2024 6:43 am Amid the rising selling pressure in the Indian stock markets, domestic brokerage firm SMC Global Securities has suggested four stocks- IPCA Laboratories Ltd, V-Guard Industries Ltd, Torrent Pharmaceuticals Ltd and Manappuram Finance Ltd- to bet amid the …
- Lilly and EVA Pharma’s Locally Manufactured Insulin Approved in Egypt December 18, 2024 9:11 pm The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company. Launched in 2022, the collaboration aims to deliver a sustainable supply of high-quality, affordable human …
- Stocks in news: Mobikwik, Vishal Mega Mart, Ambuja Cements, Adani Energy, Auro Pharma & Sai Life December 18, 2024 2:44 am Indian benchmark indices settled with big cuts on Tuesday amid the pessimism of hawkish signals from the US Federal Reserve. BSE Sensex tanked 1,064.12 points, or 1.30 per cent, to end at 80,684.45. NSE's Nifty50 crashed 332.25 points or 1.35 per cent, …
- Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt December 17, 2024 11:18 am This milestone stems from the companies' collaboration to expand access to affordable insulin to one million people living with diabetes in low- to middle-income countries annually by 2030 INDIANAPOLIS and CAIRO, Dec. 17, 2024 /PRNewswire/ -- …
- New HSR Rules: Impacts to the Pharma Industry December 16, 2024 11:21 pm Click here to listen to the audio On this Ropes & Gray podcast, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino (“HSR”) Act …
- Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma December 9, 2024 3:03 am Indian benchmark indices settled slightly lower on Friday after the RBI's monetary policy, snapping the five-day winning streak. BSE Sensex fell 56.74 points or 0.07 per cent to end at 81,709.12. NSE's Nifty50 eased 30.60 points or 0.12 per cent, …
- Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China December 6, 2024 6:53 pm Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in Singapore. GSK inked an antibody-drug conjugate deal with DualityBio and, through a revised agreement with Zhifei, dialed down its …
- Active Pharmaceutical Ingredients Market To Grow By USD 86.47 Billion (2024-2028), Driven By Evolving API Manufacturing, With AI Driving Market Transformation - Technavio December 3, 2024 12:39 am (MENAFN- PR Newswire) NEW YORK, Dec. 2, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global active Pharmaceutical ingredients market size is estimated to grow by USD 86.47 billion from 2024-2028, according to Technavio. The …
- Clariant to showcase made in India pharma products at CPHI 2024 November 26, 2024 9:38 am Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI India tradeshow in Delhi NCR on November 26 through 28, 2024. This year’s event will showcase Clariant Health Care’s Made in India …
- Stocks in news: Waaree Energies, GMR Infra, AstraZeneca, Indus Towers, Ashoka Buildcon & ITI November 19, 2024 3:09 am Indian benchmark indices settled lower on Monday, marking losses for the seventh straight session. A muted earnings season, and mixed global cues dented the sentiments at Dalal Street. BSE Sensex shed 241.30 points or 0.31 per cent to end at 77,339.01. NSE …